The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.65
Bid: 16.00
Ask: 19.30
Change: -0.20 (-1.12%)
Spread: 3.30 (20.625%)
Open: 17.85
High: 0.00
Low: 0.00
Prev. Close: 17.85
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

Fri, 29th Oct 2021 15:57

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and Friday and not separately reported by Alliance News:

----------

TP Group PLC - Wincanton, England-based consulting, software and engineering company - Philip Holland resigns as chair, effective immediately, having served for four years. Holland "made this decision in the best interests of the TP Group's employees and shareholders in order to enable the company to move forward with a new strategy", TP says. Science Group PLC, a 27% shareholder of TP, on Tuesday had requisitioned a general meeting to remove Holland, who had stepped up to chair in late September to replace Andrew McCree. Earlier this month, Martyn Ratcliffe and Peter Bertram joined the TP board to represent Science Group, which had failed in a hostile takeover offer for TP Group back in August.

----------

Futura Medical PLC - Guildford, Surrey-based pharmaceutical products for sexual health and pain - Hires Andrew Unitt as non-executive director, starting January 1. Unitt replaces Jonathan Freeman, who steps down as senior independent non-executive director on December 31. Unitt was with pharmacy chain Boots PLC for 11 years, including four as finance director of Boots Healthcare International, its over-the-counter medicines business. He currently is a non-executive director of AIM-listed diagnostics firm Oncimmune Holdings PLC.

----------

Baillie Gifford Shin Nippon PLC - invests for capital growth from small Japanese companies - Hires Claire Finn and Abigail Rotheroe as non-executive directors, with Finn starting on November 1 and Rotheroe on March 1 next year. Finn, a former executive at BlackRock Inc, is a director of London-listings Law Debenture Corp PLC and Octopus Apollo VCT PLC. Rotheroe is investment director for Snowball Impact Management, an asset manager focused on socially responsible investment. Rotheroe previously worked for Threadneedle Investments, managing Asia- and Japan-focused funds.

----------

Resolute Mining Ltd - Perth, Australia-based gold miner with projects in Mali, Senegal and Guinea - Hires Simon Jackson as non-executive director, starting Friday. Jackson replaces Yasmin Broughton, who resigned on Thursday, having served since 2017. Jackson has over 25 years experience managing mining companies, Resolute said, currently serving on several boards, including two as chair.

----------

Capital Metals PLC - mineral sands project in Sri Lanka - Hires James Mahony as chief financial officer, effective immediately, while Anthony Samaha steps down as finance director. Mahony is a partner in Westend Corporate LLP, which provides financial consulting and corporate management services. Additionally, Westend will take over as company secretary, replacing Sam Quinn.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
23 Aug 2021 15:12

Oncimmune upbeat on three-year lung cancer test study

(Sharecast News) - Immunodiagnostics group Oncimmune announced the pre-publication of the three-year follow-up data for the 'Early detection of Cancer of the Lung Scotland' (ECLS) trial on Monday, which showed that after three years, the number of late-stage cancers and deaths were lower in patients tested with the 'EarlyCDT Lung' blood test.

Read more
23 Jul 2021 12:46

Oncimmune signs agreement with major cancer centre to profile patients

Oncimmune signs agreement with major cancer centre to profile patients

Read more
23 Jul 2021 09:44

Oncimmune inks research deal with Dana-Farber Cancer Institute

(Sharecast News) - Immunodiagnostics group Oncimmune has signed an autoantibody profiling contract with Dana-Farber Cancer Institute, based in Boston, Massachusetts, it announced on Friday.

Read more
22 Jul 2021 19:40

TRADING UPDATES: Tekcapital investee and Puma VCT 13 raise funds

TRADING UPDATES: Tekcapital investee and Puma VCT 13 raise funds

Read more
8 Jun 2021 13:11

TRADING UPDATES: Nightcap toasts sales jump after May reopening

TRADING UPDATES: Nightcap toasts sales jump after May reopening

Read more
8 Jun 2021 10:57

Oncimmune FY revenues tracking in line with expectations

(Sharecast News) - Immunodiagnostics group Oncimmune said on Tuesday that 2021 full-year revenues were in line with market expectations,

Read more
1 Jun 2021 15:51

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
6 Apr 2021 16:54

IN BRIEF: Oncimmune signs separate deals with Roche and Cedars-Sinai

IN BRIEF: Oncimmune signs separate deals with Roche and Cedars-Sinai

Read more
6 Apr 2021 09:14

Oncimmune secures contracts with Roche and Cedars-Sinai

(Sharecast News) - Immunodiagnostics group Oncimmune said on Tuesday that it had signed two separate agreements for the use of its newly developed and proprietary Infectious Disease panel with Roche Pharmaceuticals and Cedars-Sinai Medical Center.

Read more
25 Mar 2021 16:46

Oncimmune secures GBP9 million in oversubscribed share placing

Oncimmune secures GBP9 million in oversubscribed share placing

Read more
25 Mar 2021 11:28

AIM WINNERS & LOSERS: Tandem rises on strong results, positive outlook

AIM WINNERS & LOSERS: Tandem rises on strong results, positive outlook

Read more
15 Feb 2021 10:30

Oncimmune Interim Loss Narrows On Higher Revenue And Lower Costs

Oncimmune Interim Loss Narrows On Higher Revenue And Lower Costs

Read more
8 Feb 2021 16:09

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
19 Jan 2021 16:30

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.